# Cue Biopharma, Inc. — Form D

Cue Biopharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-22. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-12-22
- Form: D
- Accession: 0001645460-16-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 133
- Date of first sale: 2016-12-22
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-276931

## Issuer

- Name: Cue Biopharma, Inc.
- CIK: 0001645460
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 40 GUEST STREET, BOSTON, MA, 02135
- Phone: 617-949-2680

## Officers, directors & promoters (43)

_Showing 25 of 43 people._

| Name | Role | Location |
| --- | --- | --- |
| Peter Kiener | Director | St. Louis, MO |
| Peter Kiener | Related Person | St. Louis, MO |
| Anthony DiGiandomenico | Director | Tulsa, OK |
| Christopher Marlett | Director | Addison, TX |
| Barry Simon | Director | Santa Monica, CA |
| Frank Morich | Related Person | Boston, MA |
| Dominic Borie | Related Person | Boston, MA |
| DANIEL CAMARDO | Related Person | Boston, MA |
| Amy Wang | Director | Palo Alto, CA |
| Amy Wang | Executive Officer | Palo Alto, CA |
| Tamar G Howson | Director | Boston, MA |
| Daniel R Passeri | Director | Boston, MA |
| Daniel R Passeri | Executive Officer | Boston, MA |
| Aaron G Fletcher | Director | Boston, MA |
| Peter A Kiener | Director | Boston, MA |
| Kerri-Ann R Millar | Executive Officer | Boston, MA |
| Anish R Suri | Executive Officer | Boston, MA |
| Frank G Morich | Director | Boston, MA |
| Frederick G Driscoll | Director | Boston, MA |
| Patricia R Nasshorn | Executive Officer | Boston, MA |
| Colin G Sandercock | Executive Officer | Boston, MA |
| Ken R Pienta | Executive Officer | Boston, MA |
| Cameron Gray | Director | Miami, FL |
| Cameron Gray | Executive Officer | Miami, FL |
| Viola Meehan | Related Person | Boston, MA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-07-22](https://search.stillhousedata.com/formd/0001645460-26-000004) | D | $50.0M | $50.0M |
| [2026-05-14](https://search.stillhousedata.com/formd/0001645460-26-000003) | D | $30.0M | $30.0M |
| [2022-11-21](https://search.stillhousedata.com/formd/0001645460-22-000005) | D | $30.0M | $30.0M |
| [2016-12-30](https://search.stillhousedata.com/formd/0001645460-16-000005) | D/A | $16.4M | $16.4M |
| [2015-06-19](https://search.stillhousedata.com/formd/0001140361-15-024836) | D | $10.0M | $10.0M |
| [2015-06-19](https://search.stillhousedata.com/formd/0001140361-15-024837) | D | $1.0M | — |

## More

- [CIK 1645460 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1645460&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001645460-16-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.